Skip to main content
Panacea Biotec Ltd. logo

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Open in API
Filings indexed 794 across all filing types
Latest filing 2023-06-07 Regulatory Filings
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges and depositories providing details of shares dematerialized during May 2023, including a certificate from the company's registrar and share transfer agent. It references Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which governs share dematerialization reporting. The content is an official notification of share dematerialization data rather than a financial report, earnings release, or management discussion. It is not a report itself but an announcement of share dematerialization details for regulatory compliance. The document length is under 5,000 characters and primarily serves as a regulatory filing informing exchanges and depositories of share dematerialization status. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-06-07 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains multiple references to audited financial results for the quarter and financial year ended March 31, 2023, including standalone and consolidated results. It mentions compliance under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and includes detailed financial data such as total income, net profit/loss, equity share capital, and earnings per share. The document also includes extracts of audited financial results published in newspapers, which are typical for quarterly and annual financial reporting. The presence of detailed financial figures and the mention of quarterly and annual periods indicate this is a financial report rather than a mere announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR) as it contains substantive financial data for a period shorter than a full fiscal year (quarterly and half-yearly results).
2023-05-31 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions for the half year ended March 31, 2023, submitted pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. It includes detailed tables of transactions between the company and related parties, including loans, remuneration, rental income, and interest. The document is addressed to stock exchanges and is a regulatory compliance filing rather than a financial report or management discussion. It does not contain comprehensive financial statements or management analysis but is a regulatory disclosure of related party transactions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2023-05-30 English
Updates
Regulatory Filings
2023-05-30 English
Annual Secretarial Compliance Report
Regulatory Filings
2023-05-30 English
Financial Result Updates
Regulatory Filings
2023-05-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.